NOT-NS-19-074: Notice of Change to Application Types Allowed for RFA-NS-18-023 "BRAIN Initiative: Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Required)"

Notice of Change to Application Types Allowed for RFA-NS-18-023 "BRAIN Initiative: Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Required)"

Notice Number: NOT-NS-19-074

Key Dates
Release Date: June 28, 2019

Related Announcements
RFA-NS-18-023

Issued by
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute on Deafness and Other Communication Disorders (NIDCD)

Purpose

The purpose of this notice is to inform applicants that revision applications will be accepted in response to RFA-NS-18-023 "BRAIN Initiative: Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Required)". Changes are listed below (in bold italics). This notice will be effective for the October 21, 2019 due date and subsequent due dates.

Currently Reads:

Section II. Award Information

Application Types Allowed?

New

Resubmission

Modified to Read:

Section II. Award Information

Application Types Allowed

New

Resubmission

Revision

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Nick Langhals, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1779
Email: [email protected]